Advent Venture Partners completes first financing round for pharma investment

Advent Venture Partners, a London-based venture capital firm, has invested €15m in Speciality European Pharma in the first substantial financing round.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this